跳至主要内容
临床试验/CTRI/2013/08/003910
CTRI/2013/08/003910招募中未知

A population-based survey of the prevalence of hepatitis C virus infection in Punjab, North India

MSD Pharmaceuticals Private Limited A subsidiary of Merck Co Inc0 个研究点目标入组 5,500 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
5,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Household members greater than five years of age who have provided voluntary informed consent for participation (For adults aged more than 18 years informed consent will be taken. For
  • children aged more than 5 years and less than 18 years, assent along with
  • informed consent by parents or legally acceptable
  • representative [LAR] will be taken).

排除标准

  • Children aged less than 5 years

研究者

发起方
MSD Pharmaceuticals Private Limited A subsidiary of Merck Co Inc

相似试验